1. Home
  2. IZTC vs PFO Comparison

IZTC vs PFO Comparison

Compare IZTC & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZTC
  • PFO
  • Stock Information
  • Founded
  • IZTC 2019
  • PFO 1991
  • Country
  • IZTC United States
  • PFO United States
  • Employees
  • IZTC N/A
  • PFO N/A
  • Industry
  • IZTC Biotechnology: Biological Products (No Diagnostic Substances)
  • PFO Finance Companies
  • Sector
  • IZTC Health Care
  • PFO Finance
  • Exchange
  • IZTC Nasdaq
  • PFO Nasdaq
  • Market Cap
  • IZTC 111.5M
  • PFO 118.2M
  • IPO Year
  • IZTC 2024
  • PFO N/A
  • Fundamental
  • Price
  • IZTC $10.56
  • PFO $9.08
  • Analyst Decision
  • IZTC
  • PFO
  • Analyst Count
  • IZTC 0
  • PFO 0
  • Target Price
  • IZTC N/A
  • PFO N/A
  • AVG Volume (30 Days)
  • IZTC 52.0K
  • PFO 31.8K
  • Earning Date
  • IZTC 02-15-2025
  • PFO 01-01-0001
  • Dividend Yield
  • IZTC N/A
  • PFO 6.51%
  • EPS Growth
  • IZTC N/A
  • PFO N/A
  • EPS
  • IZTC N/A
  • PFO N/A
  • Revenue
  • IZTC N/A
  • PFO N/A
  • Revenue This Year
  • IZTC N/A
  • PFO N/A
  • Revenue Next Year
  • IZTC N/A
  • PFO N/A
  • P/E Ratio
  • IZTC N/A
  • PFO N/A
  • Revenue Growth
  • IZTC 145.01
  • PFO N/A
  • 52 Week Low
  • IZTC $8.50
  • PFO $6.90
  • 52 Week High
  • IZTC $23.00
  • PFO $8.51
  • Technical
  • Relative Strength Index (RSI)
  • IZTC N/A
  • PFO 50.73
  • Support Level
  • IZTC N/A
  • PFO $9.05
  • Resistance Level
  • IZTC N/A
  • PFO $9.20
  • Average True Range (ATR)
  • IZTC 0.00
  • PFO 0.13
  • MACD
  • IZTC 0.00
  • PFO 0.01
  • Stochastic Oscillator
  • IZTC 0.00
  • PFO 70.00

About IZTC Invizyne Technologies Inc. Common Stock

Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: